What is it about?
Summary of the pertinent discussions, presentations, and posters from the meeting sessions. Covers the hot topics that are being discussed in the industry with the regulators involved.
Featured Image
Read the Original
This page is a summary of: 2017 White Paper on recent issues in bioanalysis: a global perspective on immunogenicity guidelines & biomarker assay performance (Part 3 – LBA: immunogenicity, biomarkers and PK assays), Bioanalysis, December 2017, Future Science,
DOI: 10.4155/bio-2017-4974.
You can read the full text:
Contributors
The following have contributed to this page
